Drug & Supplement Interactions

Cannabidiol (CBD) + Aprepitant

Brand names of Aprepitant

  • Emend
  • Cinvanti
  • Aponvie

Medically reviewed by

Also reviewed by the HelloPharmacist Editorial Team

Updated November 2026Details about this page

AI is used only to summarize verified clinical information, never the open internet. Our AI policy

The Bottom Line Moderate Interaction

Cannabidiol may increase levels of drugs that are metabolized by CYP3A4. Of the 3 interaction records for this pair, the most serious is rated moderate.

This also applies to Emend, Cinvanti and Aponvie, brand names of aprepitant.

Read the Full Interaction Report

Dr. Brian Staiger’s Quick Take

CBD may slow how quickly aprepitant (Emend, Cinvanti) is cleared, so levels could climb and bring more tiredness, hiccups, headache, dizziness, or upset stomach. Since it's usually a short course around chemo, check with your oncology pharmacist or doctor before using any CBD product.

Read his full note1-minute read
Moderate
Probable
3
AOthers: D

Ask a Question About This Combination

Ask in your own words about taking Cannabidiol (CBD) with Aprepitant. The answer comes from this page’s own records.

Try:

AI answers from this page’s interaction records and our own drug and supplement information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist. How we use AI

Interaction Report

Cannabidiol (CBD) and Aprepitant Interaction

3 interaction records apply to these two. Each one is explained separately below.

Why Are There 3 Interaction Records?

We file Cannabidiol (CBD)’s interactions under single medicines and under categories of medicines that share an effect. Aprepitant is named in, or belongs to, 3 of them, so 3 records apply. They can describe the same effect, so they are not 3 separate risks. We’ve listed each one below; the most serious of them (Moderate) sets the overall rating.

Moderate Interaction 1 of 3

Cannabidiol (CBD) With Cytochrome P450 3A4 (CYP3A4) Substrates

Why this applies to Aprepitant

  1. The SupplementCannabidiol (CBD)
  2. Interacts With the CategoryCytochrome P450 3A4 (CYP3A4) Substrates
  3. Which IncludesAprepitant

We sort drugs into categories. Aprepitant is in our Cytochrome P450 3A4 (CYP3A4) Substrates category, and Cannabidiol (CBD) interacts with every drug in it, so this interaction applies to Aprepitant.

Interaction Details Explained

Cannabidiol may increase levels of drugs that are metabolized by CYP3A4.
In vitro and animal research shows that cannabidiol inhibits CYP3A4. In human studies and case reports, cannabidiol has been associated with an increase in plasma levels of the CYP3A4 substrates zonisamide, tacrolimus, everolimus, citalopram, midazolam, and methadone.
Severity
ModerateUse caution: it may call for monitoring, timing changes or a dose change.
Likelihood
ProbableShown in small studies in people, or in animal studies backed by case reports.
Evidence
Grade ABased on a well-run randomized trial, where people are assigned at random to the supplement or a comparison.

What every rating means

Dr. Brian Staiger, PharmD, BCPS
Explaining the Cannabidiol (CBD) + Cytochrome P450 3A4 (CYP3A4) Substrates Interaction in Plain Words By Dr. Brian Staiger, PharmD, clinical pharmacist

Here's the gist for aprepitant (Emend, Cinvanti). Your body relies on a liver enzyme called CYP3A4 to break it down and clear it out. CBD can put the brakes on that same enzyme, so aprepitant may not be cleared as quickly and its levels can creep up. Aprepitant is not a prodrug, so more of it in your blood means stronger effects and a bigger chance of side effects like tiredness, hiccups, headache, dizziness, or an upset stomach.

The good news is this is usually a short course of aprepitant given around chemo, so the overlap is brief. Still, since you're going through treatment, please run any CBD product past your oncology pharmacist or doctor first so they can keep an eye on you.

Still have a question about this interaction?

Contact Dr. Brian directly

References 11 sources behind this record

  1. Yamaori S, Ebisawa J, Okushima Y, et al. Potent inhibition of human cytochrome P450 3A isoforms by cannabidiol: role of phenolic hydroxyl groups in the resorcinol moiety. Life Sci 2011;88(15-16):730-6. PubMed
  2. Harvey DJ. Absorption, distribution, and biotransformation of the cannabinoids. Marijuana and Medicine. 1999;91-103. DOI
  3. Bornheim LM, Everhart ET, Li J, Correia MA. Characterization of cannabidiol-mediated cytochrome P450 inactivation. Biochem Pharmacol 1993;45(6):1323-31. PubMed
  4. Gaston TE, Bebin EM, Cutter GR, Liu Y, Szaflarski JP; UAB CBD Program. Interactions between cannabidiol and commonly used antiepileptic drugs. Epilepsia. 2017 Sep;58(9):1586-92. PubMed
  5. Leino AD, Emoto C, Fukuda T, Privitera M, Vinks AA, Alloway RR. Evidence of a clinically significant drug-drug interaction between cannabidiol and tacrolimus. Am J Transplant. 2019;19(10):2944-2948. PubMed
  6. Wiemer-Kruel A, Stiller B, Bast T. Cannabidiol Interacts Significantly with Everolimus-Report of a Patient with Tuberous Sclerosis Complex. Neuropediatrics. 2019. PubMed
  7. Madden K, Tanco K, Bruera E. Clinically Significant Drug-Drug Interaction Between Methadone and Cannabidiol. Pediatrics. 2020;e20193256. PubMed
  8. Anderson LL, Doohan PT, Oldfield L, et al. Citalopram and Cannabidiol: In Vitro and In Vivo Evidence of Pharmacokinetic Interactions Relevant to the Treatment of Anxiety Disorders in Young People. J Clin Psychopharmacol. 2021. PubMed
  9. Nasrin S, Watson CJW, Perez-Paramo YX, Lazarus P. Cannabinoid Metabolites as Inhibitors of Major Hepatic CYP450 Enzymes, with Implications for Cannabis-Drug Interactions. Drug Metab Dispos 2021;49(12):1070-1080. PubMed
  10. Treyer A, Reinhardt JK, Eigenmann DE, Oufir M, Hamburger M. Phytochemical comparison of medicinal cannabis extracts and study of their CYP-mediated interactions with coumarinic oral anticoagulants. Med Cannabis Cannabinoids. 2023;6(1):21-31. PubMed
  11. Bansal S, Zamarripa CA, Spindle TR, et al. Evaluation of Cytochrome P450-Mediated Cannabinoid-Drug Interactions in Healthy Adult Participants. Clin Pharmacol Ther 2023.
Moderate Interaction 2 of 3

Cannabidiol (CBD) With Cytochrome P450 3A4 (CYP3A4) Inhibitors

Aprepitant is also in our Cytochrome P450 3A4 (CYP3A4) Inhibitors category.

Interaction Details Explained

Theoretically, CYP3A4 inhibitors might increase cannabidiol levels.
Cannabidiol is a substrate of CYP3A4 enzymes. Theoretically, drugs that inhibit CYP3A4 enzymes might increase levels of cannabidiol, increasing its effects and adverse effects.
Severity
ModerateUse caution: it may call for monitoring, timing changes or a dose change.
Likelihood
PossibleSeen in lab or animal research, or in people only in case reports or mixed results.
Evidence
Grade DBased on what is expected from how the two work, not yet studied.

What every rating means

Dr. Brian Staiger, PharmD, BCPS
Explaining the Cannabidiol (CBD) + Cytochrome P450 3A4 (CYP3A4) Inhibitors Interaction in Plain Words By Dr. Brian Staiger, PharmD, clinical pharmacist

Here's the gist if you're using CBD around the time you get aprepitant (Emend) for chemo nausea. Aprepitant gently slows down a liver enzyme called CYP3A4, and that same enzyme is one of the main ways your body clears CBD. So in theory, CBD could hang around a bit longer and feel stronger than usual.

What that might look like in real life is more of CBD's usual effects, like drowsiness, lightheadedness, dry mouth, or an upset stomach. The good news is this is a theoretical concern based on how the drugs work, not something proven in studies, and aprepitant is typically only used for a few days around chemo. Still, since you're already going through treatment, please run your CBD product by your oncology pharmacist or doctor first so they can keep an eye on you.

Still have a question about this interaction?

Contact Dr. Brian directly

References 1 source behind this record

  1. Product information for Marinol. AbbVie. North Chicago, IL 60064. August 2017. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/018651s029lbl.pdf.
Moderate Interaction 3 of 3

Cannabidiol (CBD) With Cytochrome P450 3A4 (CYP3A4) Inducers

Aprepitant is also in our Cytochrome P450 3A4 (CYP3A4) Inducers category.

Interaction Details Explained

Theoretically, CYP3A4 inducers might decrease cannabidiol levels.
Cannabidiol is a substrate of CYP3A4 enzymes. Theoretically, drugs that induce CYP3A4 enzymes might reduce the levels and effects of cannabidiol.
Severity
ModerateUse caution: it may call for monitoring, timing changes or a dose change.
Likelihood
PossibleSeen in lab or animal research, or in people only in case reports or mixed results.
Evidence
Grade DBased on what is expected from how the two work, not yet studied.

What every rating means

Dr. Brian Staiger, PharmD, BCPS
Explaining the Cannabidiol (CBD) + Cytochrome P450 3A4 (CYP3A4) Inducers Interaction in Plain Words By Dr. Brian Staiger, PharmD, clinical pharmacist

Here's the thing to keep in mind about this pairing: it's really about what happens to your CBD, not your aprepitant. Aprepitant can act as a mild inducer of CYP3A4, the same liver enzyme that helps break down CBD. So in theory, taking them together could speed up how fast your body clears the CBD, leaving you with lower CBD levels and a weaker effect than you'd expect.

This is a theoretical concern based on how these drugs behave, not something proven in real patients, so I wouldn't lose sleep over it. Aprepitant itself is only used for a short stretch around your chemo, so any effect would be temporary. Still, since CBD products vary so much and you're going through cancer treatment, please run it by your oncology pharmacist or doctor before mixing the two.

Still have a question about this interaction?

Contact Dr. Brian directly

References 1 source behind this record

  1. Epidiolex (cannabidiol) prescribing information. Greenwich Biosciences, Inc., Carlsbad, CA, 2019. Available at: https://www.epidiolex.com/sites/default/files/EPIDIOLEX_Full_Prescribing_Information.pdf (accessed 5/9/2019)
Know someone taking this combination? Share

Your Whole Routine

Your Other Medicines and Supplements

Keep It in Perspective

Cannabidiol (CBD) Also Interacts With Other Medications

Besides Aprepitant, Cannabidiol (CBD) has 1,052 moderate known drug interactions in our database. If you take anything else, check it against the full list below.

Taking Anything Else?

Check Another of Your Medications Against Cannabidiol (CBD)

Covers the 2,830 medications we’ve checked against Cannabidiol (CBD). Pick one to open its full report.

Everything Else You Take

See Every Supplement That Interacts With Aprepitant

Take other supplements too? 163 supplements have a documented interaction with Aprepitant, each explained on its page.

By severity: 3 major, 119 moderate and 41 minor.

The Most Serious There Right Now:

Open the Aprepitant interaction pageEvery supplement checked against Aprepitant, ranked by severity

Get to Know Each One

About Cannabidiol (CBD) and Aprepitant

Supplement

About Cannabidiol (CBD)

CBD is a compound from the cannabis (hemp) plant that does not cause a 'high.' It has strong evidence only for certain rare seizure disorders (as a prescription drug), while most other popular uses are still backed by limited or early research. Product quality varies a lot, so talk with your pharmacist or doctor before using it, especially if you take other medicines.

Full Cannabidiol (CBD) guide: uses, dosage, safety and every interaction
Medication

About Aprepitant

Brand names: Emend, Cinvanti, Aponvie

Aprepitant products are used, together with other anti-nausea medicines, to prevent nausea and vomiting from cancer chemotherapy. This includes highly emetogenic chemotherapy (HEC), such as high-dose cisplatin, and moderately emetogenic chemotherapy (MEC). “Emetogenic” means likely to cause vomiting.

Aprepitant: uses, dosage and side effects Aprepitant: interactions with other drugs Taking more than these two? Check Cannabidiol (CBD) and Aprepitant with everything else you take Aprepitant NDC codes and packages

More to Explore

More Pairs and Interactions to Check

Similar Pairs

More Pairs Like Cannabidiol (CBD) and Aprepitant

Other drugs in the category this interaction applies to, and other supplements people check with Aprepitant.

Moderate

Also in Our Cytochrome P450 3A4 (CYP3A4) Inhibitors Category

Cannabidiol (CBD) interacts with every drug in this category, so each of these has the same interaction. The category is about a shared effect, not about being the same kind of medicine.

Show all 16 drugs in this categoryShow fewer

146 more in this category are on the Cannabidiol (CBD) interactions list.

Moderate

Also in Our Cytochrome P450 3A4 (CYP3A4) Substrates Category

Cannabidiol (CBD) interacts with every drug in this category, so each of these has the same interaction. The category is about a shared effect, not about being the same kind of medicine.

Show all 16 drugs in this categoryShow fewer

383 more in this category are on the Cannabidiol (CBD) interactions list.

Moderate

Also in Our Cytochrome P450 3A4 (CYP3A4) Inducers Category

Cannabidiol (CBD) interacts with every drug in this category, so each of these has the same interaction. The category is about a shared effect, not about being the same kind of medicine.

Show all 16 drugs in this categoryShow fewer

70 more in this category are on the Cannabidiol (CBD) interactions list.

Other Supplements With Aprepitant

The most serious documented interactions with Aprepitant first, then supplements with none on record, the most looked-up leading.

Show all 27 supplementsShow fewer
Keep Checking

Other Drugs & Cannabidiol (CBD)

Browse every other medication we’ve checked against Cannabidiol (CBD) — both the ones with a known interaction and the ones without. Select any drug for the full detail.

0Major
1,052Moderate
0Minor
1,777No known interaction
Moderate

Moderate: 1,052 interactions

Showing 60 of 1,052 moderate interactions — see all 1,052 on the Cannabidiol (CBD) page.

No Interaction 1,777 drugs checked — show the list

We also checked Cannabidiol (CBD) against these medications and found no known interaction in our sources. Open any page to confirm.

Showing 60 of the 1,777 medications checked with no known interaction, the most looked-up first — see the full Cannabidiol (CBD) list.

How Much People Look This Up

Where Cannabidiol (CBD) and Aprepitant Sit Against Everything Else

Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.

Supplement Cannabidiol (CBD)
Top 25%

#356 of 1,458 supplements looked up here in the last 7 days

29 days ago today
Medication Aprepitant
Top 25%

#364 of 2,830 medications looked up here in the last 7 days

29 days ago today

A rank of lookups on this site, not of how often either one is used. It counts every visit, automated ones included, and identifies no one.

Questions and Sources

Common Questions and Where This Comes From

Pharmacist Counseling Corner

Taking Cannabidiol (CBD) and Aprepitant Together: Common Questions

Can you take Cannabidiol (CBD) with Aprepitant?
There is a moderate interaction, so it may be acceptable with monitoring or timing changes. Read the full details on this page and confirm with your pharmacist before combining them.
Can you take Cannabidiol (CBD) with Emend?
Emend is a brand name of aprepitant, and so are Cinvanti and Aponvie, so the answer is the same as for aprepitant. There is a moderate interaction, so it may be acceptable with monitoring or timing changes. Everything on this page applies to Emend too.
Why are there 3 interaction records for Cannabidiol (CBD) and Aprepitant?
We file interactions under single medicines and under categories of medicines that share an effect. Aprepitant is named in, or belongs to, 3 of the categories we list for Cannabidiol (CBD), so 3 records apply. They can describe the same effect, so they are not 3 separate risks. We list every one so nothing is missed, and the most serious one sets the overall rating.
How serious is the Cannabidiol (CBD) and Aprepitant interaction?
We rate it Moderate. This combination may require monitoring, a dose adjustment, or separating the times you take each one. Consult your pharmacist before using them together.

Written and reviewed by the HelloPharmacist Editorial Team. Our editorial policy

Sources

Sources & How We Checked

Interaction details are evidence-graded and sourced from the Natural Medicines database. The medication overview comes from MedlinePlus.

Content is reviewed by the HelloPharmacist Editorial Team, the pharmacists on our staff and those we contract. See our data sources and editorial standards for how this information is built and checked.

Parts of this content are provided by the Therapeutic Research Center, LLC.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Keep Exploring
Rating Key

What Our Interaction Ratings Mean

Every interaction on this page is rated three ways: how serious it is, how likely it is to happen, and how strong the research behind it is.

See what each rating means

Severity: How Serious Is It?

How clinically significant the interaction is: how much it could affect your health or your treatment.

  • MajorClinically significant. Best to avoid the combination, or use only under close professional supervision.
  • ModerateBe cautious. The combination may call for monitoring, timing changes, or a dose adjustment.
  • MinorLimited clinical concern, but still worth being aware of and mentioning to your pharmacist.
  • No Known InteractionNo documented interaction in our sources.

Likelihood: How Likely Is It to Happen?

How strong the proof is that the interaction really happens in people. More filled steps, stronger proof.

  • LikelyShown in well-controlled studies in people.
  • ProbableShown in small studies in people, or in animal studies backed by case reports.
  • PossibleSeen in lab or animal research, or in people only in case reports or mixed results.
  • UnlikelySeen in lab or animal research, but shown not to happen in people.

Evidence: How Strong Is the Research?

The quality of the studies behind the rating, graded from A, the strongest, to D.

  • Grade AStrong: well-run randomized trials in people, or a review that pooled several of them.
  • Grade BFair: smaller or less rigorous trials in people, or studies that followed or compared groups of people.
  • Grade CLimited: the agreement or opinion of experts, not studies.
  • Grade DWeak: reports of single cases, lab or animal research, or what is expected from how the two work.

Still Have a Question About Cannabidiol (CBD) and Aprepitant?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.